218 related articles for article (PubMed ID: 33454370)
1. Association of gut-related metabolites with outcome in acute heart failure.
Israr MZ; Bernieh D; Salzano A; Cassambai S; Yazaki Y; Heaney LM; Jones DJL; Ng LL; Suzuki T
Am Heart J; 2021 Apr; 234():71-80. PubMed ID: 33454370
[TBL] [Abstract][Full Text] [Related]
2. Surrogate markers of gut dysfunction are related to heart failure severity and outcome-from the BIOSTAT-CHF consortium.
Israr MZ; Zhan H; Salzano A; Voors AA; Cleland JG; Anker SD; Metra M; van Veldhuisen DJ; Lang CC; Zannad F; Samani NJ; Ng LL; Suzuki T;
Am Heart J; 2022 Jun; 248():108-119. PubMed ID: 35278373
[TBL] [Abstract][Full Text] [Related]
3. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
[TBL] [Abstract][Full Text] [Related]
4. Associations of plasma trimethylamine N-oxide, choline, carnitine, and betaine with inflammatory and cardiometabolic risk biomarkers and the fecal microbiome in the Multiethnic Cohort Adiposity Phenotype Study.
Fu BC; Hullar MAJ; Randolph TW; Franke AA; Monroe KR; Cheng I; Wilkens LR; Shepherd JA; Madeleine MM; Le Marchand L; Lim U; Lampe JW
Am J Clin Nutr; 2020 Jun; 111(6):1226-1234. PubMed ID: 32055828
[TBL] [Abstract][Full Text] [Related]
5. Association of Trimethylamine N-Oxide and Related Metabolites in Plasma and Incident Type 2 Diabetes: The Cardiovascular Health Study.
Lemaitre RN; Jensen PN; Wang Z; Fretts AM; McKnight B; Nemet I; Biggs ML; Sotoodehnia N; de Oliveira Otto MC; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
JAMA Netw Open; 2021 Aug; 4(8):e2122844. PubMed ID: 34448864
[TBL] [Abstract][Full Text] [Related]
6. Choline Metabolism and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Study.
Papandreou C; Bulló M; Hernández-Alonso P; Ruiz-Canela M; Li J; Guasch-Ferré M; Toledo E; Clish C; Corella D; Estruch R; Ros E; Fitó M; Alonso-Gómez A; Fiol M; Santos-Lozano JM; Serra-Majem L; Liang L; Martínez-González MA; Hu FB; Salas-Salvadó J
Clin Chem; 2021 Jan; 67(1):288-297. PubMed ID: 33257943
[TBL] [Abstract][Full Text] [Related]
7. Trimethylamine N-oxide and prognosis in acute heart failure.
Suzuki T; Heaney LM; Bhandari SS; Jones DJ; Ng LL
Heart; 2016 Jun; 102(11):841-8. PubMed ID: 26869641
[TBL] [Abstract][Full Text] [Related]
8. Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation.
Kuka J; Liepinsh E; Makrecka-Kuka M; Liepins J; Cirule H; Gustina D; Loza E; Zharkova-Malkova O; Grinberga S; Pugovics O; Dambrova M
Life Sci; 2014 Nov; 117(2):84-92. PubMed ID: 25301199
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous quantification of trimethylamine N-oxide, trimethylamine, choline, betaine, creatinine, and propionyl-, acetyl-, and L-carnitine in clinical and food samples using HILIC-LC-MS.
Hefni ME; Bergström M; Lennqvist T; Fagerström C; Witthöft CM
Anal Bioanal Chem; 2021 Sep; 413(21):5349-5360. PubMed ID: 34258650
[TBL] [Abstract][Full Text] [Related]
10. Association of Trimethylamine N-Oxide and Metabolites With Mortality in Older Adults.
Fretts AM; Hazen SL; Jensen P; Budoff M; Sitlani CM; Wang M; de Oliveira Otto MC; DiDonato JA; Lee Y; Psaty BM; Siscovick DS; Sotoodehnia N; Tang WHW; Lai H; Lemaitre RN; Mozaffarian D
JAMA Netw Open; 2022 May; 5(5):e2213242. PubMed ID: 35594043
[TBL] [Abstract][Full Text] [Related]
11. Effects of dietary choline, betaine, and L-carnitine on the generation of trimethylamine-N-oxide in healthy mice.
Yu ZL; Zhang LY; Jiang XM; Xue CH; Chi N; Zhang TT; Wang YM
J Food Sci; 2020 Jul; 85(7):2207-2215. PubMed ID: 32572979
[TBL] [Abstract][Full Text] [Related]
12. Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure.
Tang WH; Wang Z; Shrestha K; Borowski AG; Wu Y; Troughton RW; Klein AL; Hazen SL
J Card Fail; 2015 Feb; 21(2):91-6. PubMed ID: 25459686
[TBL] [Abstract][Full Text] [Related]
13. The carnitine-butyrobetaine-TMAO pathway after cardiac transplant: Impact on cardiac allograft vasculopathy and acute rejection.
Trøseid M; Mayerhofer CCK; Broch K; Arora S; Svardal A; Hov JR; Andreassen AK; Gude E; Karason K; Dellgren G; Berge RK; Gullestad L; Aukrust P; Ueland T
J Heart Lung Transplant; 2019 Oct; 38(10):1097-1103. PubMed ID: 31301965
[TBL] [Abstract][Full Text] [Related]
14. Changes in the concentrations of trimethylamine N-oxide (TMAO) and its precursors in patients with amyotrophic lateral sclerosis.
Chen L; Chen Y; Zhao M; Zheng L; Fan D
Sci Rep; 2020 Sep; 10(1):15198. PubMed ID: 32938991
[TBL] [Abstract][Full Text] [Related]
15. Renal function is associated with plasma trimethylamine-N-oxide, choline, L-carnitine and betaine: a pilot study.
Guo F; Dai Q; Zeng X; Liu Y; Tan Z; Zhang H; Ouyang D
Int Urol Nephrol; 2021 Mar; 53(3):539-551. PubMed ID: 32945995
[TBL] [Abstract][Full Text] [Related]
16. Ruminant meat and milk contain δ-valerobetaine, another precursor of trimethylamine N-oxide (TMAO) like γ-butyrobetaine.
Servillo L; D'Onofrio N; Giovane A; Casale R; Cautela D; Castaldo D; Iannaccone F; Neglia G; Campanile G; Balestrieri ML
Food Chem; 2018 Sep; 260():193-199. PubMed ID: 29699662
[TBL] [Abstract][Full Text] [Related]
17. The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis.
Skagen K; Trøseid M; Ueland T; Holm S; Abbas A; Gregersen I; Kummen M; Bjerkeli V; Reier-Nilsen F; Russell D; Svardal A; Karlsen TH; Aukrust P; Berge RK; Hov JE; Halvorsen B; Skjelland M
Atherosclerosis; 2016 Apr; 247():64-9. PubMed ID: 26868510
[TBL] [Abstract][Full Text] [Related]
18. Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery.
Trøseid M; Hov JR; Nestvold TK; Thoresen H; Berge RK; Svardal A; Lappegård KT
Metab Syndr Relat Disord; 2016 May; 14(4):197-201. PubMed ID: 27081744
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD).
Amrein M; Li XS; Walter J; Wang Z; Zimmermann T; Strebel I; Honegger U; Leu K; Schäfer I; Twerenbold R; Puelacher C; Glarner N; Nestelberger T; Koechlin L; Ceresa B; Haaf P; Bakula A; Zellweger M; Hazen SL; Mueller C
Clin Res Cardiol; 2022 Jun; 111(6):692-704. PubMed ID: 35220448
[TBL] [Abstract][Full Text] [Related]
20. Associations of serum trimethylamine N-oxide and its precursors with colorectal cancer risk in the Prostate, Lung, Colorectal, Ovarian Cancer Screening Trial Cohort.
Byrd DA; Zouiouich S; Karwa S; Li XS; Wang Z; Sampson JN; Loftfield E; Huang WY; Hazen SL; Sinha R
Cancer; 2024 Jun; 130(11):1982-1990. PubMed ID: 38285606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
